MarkR.KaplanMD

PubMed

• 10 citations
  Rapid Change in Residual Renal Function Decline Is Associated with Lower Survival and Worse Residual Renal Function Preservation in Peritoneal Dialysis Patients
  Susie L. Hu, Priyanka Joshi, Mark Kaplan, Judy Lefkovitz, Andreea Poenariu, Lance D. Dworkin, Dominique S. Michaud> ;Peritoneal Dialysis International. 2017 Jul 1
• Dose-Response and Efficacy of Ferric Citrate to Treat Hyperphosphatemia in Hemodialysis Patients: A Short-Term Randomized Trial
  Steven Zeig, Mark J Koury, Jamie P Dwyer, Gerald Schulman, Ingrid J Chang, Julia B Lewis, Mark Kaplan> ;Elsevier. 2013 May
• The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients.
  Spinowitz, B.S., Schwenk, M.H., Jacobs, P.M., Bolton, W.K., Kaplan, M.R., Charytan, C., Galler, M.> ;Kidney Int. 2005 Oct
• First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl.
  Martin, K. J., Jüppner, H., Sherrard, D. J., Goodman, W. G., Kaplan, M. R., Nassar, G., Campbell, P., Curzi, M., Charytan, C., McCary, L. C., Guo, M. D., Turner, S. A....> ;Kidney Int. 2005 Sep
• 8 citations
  A preference study: calcium acetate tablets versus gelcaps in hemodialysis patients.
  Mark R Kaplan, Cindy L Stashenko, Andra L. Bledsoe, John McGowan> ;Nephrology Nursing Journal. 2002 Aug 1
• Join now to see all